Did Hedge Funds Catch A Break With BioMarin Pharmaceutical Inc. (BMRN)?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Biomarin Pharmaceutical Inc (BMRN)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Baker Bros. Advisors Julian Baker And Felix Baker | 7,620,494 | $587,540 | 3.37% | |
| 2. | Viking Global Andreas Halvorsen | 3,752,393 | $289,310 | +31% | 1.16% |
| 3. | VenBio Select Advisor Kurt Von Emster | 3,035,000 | $233,999 | +9% | 4.27% |
| 4. | Palo Alto Investors William Leland Edwards | 2,139,614 | $164,964 | -4% | 12.75% |
| 5. | Citadel Investment Group Ken Griffin | 2,090,403 | $161,170 | +54% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $78.84 | 900 | Director | 30,740 | 2020-08-31 | Filing | |
| $78.22 | 11,900 | Director | 29,840 | 2020-08-31 | Filing | |
| $21.76 | 161 | Officer | 100,574 | 2012-10-31 | Filing | |
| $21.76 | 548 | Officer | 15,294 | 2012-10-31 | Filing | |
| $27.91 | 588 | Officer | 23,245 | 2012-10-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $81.00 | 20,000 | Officer, Director | 335,324 | 2022-05-06 | Filing | |
| $84.14 | 10,000 | Officer, Director | 335,324 | 2022-05-05 | Filing | |
| $84.50 | 9,762 | Officer | 38,639 | 2022-05-04 | Filing | |
| $84.50 | 2,038 | Officer | 38,639 | 2022-05-04 | Filing | |
| $82.12 | 18 | Director | 104,014 | 2022-05-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 1,551,617 | $119,629,672 | 0.05% | |
| 2. | 174,236 | $13,433,596 | 0.07% | |
| 3. | 17,779,470 | $1,370,797 | 1.03% | |
| 4. | 16,502,243 | $1,272,322 | 0.03% | |
| 5. | 15,034,999 | $1,159,198 | 0.7% |
News See All
10 Jim Cramer Stocks to Buy in Q1 2022
Investors have been scrambling to identify the “real value” of stocks as reports suggest that as many as four interest rate hikes by the Federal Reserve are on the horizon for 2022.
Is BioMarin Pharmaceutical Inc. (BMRN) A Good Stock To Buy?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
10 Healthcare and Software Stocks to Buy According to Michel Massoud’s Melqart Asset Management
In this article, we take a look at the 10 healthcare and software stocks to buy according to Michel Massoud’s Melqart Asset Management.
5 Biotech and Pharmaceutical Stocks to Buy According to Palo Alto Investors
In this article, we will discuss 5 biotech and pharmaceutical stocks to buy according to Palo Alto Investors based on Q2 holdings of the fund.
5 Best Genomic Stocks to Buy Now
In this article, we will take a look at the 5 best genomic stocks to buy now.
Hedge Funds Are Nibbling On BioMarin Pharmaceutical Inc. (BMRN)
A whopping number of 13F filings filed with U.S.
10 Stocks Stanley Druckenmiller is Selling
In this article, we discuss the 10 stocks Stanley Druckenmiller is selling.
Is BioMarin Pharmaceutical Inc. (BMRN) A Good Stock To Buy?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change their opinion towards a...
Here’s Why ClearBridge Sold its BioMarin Pharmaceutical (BMRN) Position
ClearBridge Investments, an investment management firm, published its “SMID Cap Growth Strategy” first quarter 2021 investor letter – a copy of which can be downloaded here.
Billionaire Hedge Funds
